CMV Disease In Stem Cell Transplantation: Prevention And Drug Resistance

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Stem Cell Research
Article Date: 15 Aug 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in recipients of hematopoietic stem cell transplantation. The clinical manifestations of CMV disease are serious and range from gastrointestinal disease to life-threatening pneumonia, myelosuppression, retinitis, and encephalitis.

In order to prevent CMV infection and reduce CMV drug resistance, it is vital that healthcare professionals involved in the treatment of hematopoietic stem cell transplant recipients understand current strategies for management of CMV, including prophylaxis and treatment. To address the need for education on CMV management, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) have jointly sponsored a free continuing education monograph for physicians and clinical pharmacists.

Faculty authors for this activity include infectious disease experts Michael J. Boeckh, MD, from the Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine in Seattle, Washington and Sunwen Chou, MD, from the Oregon Health & Science University in Portland, Oregon.

This continuing education activity is jointly sponsored by RMEI and Postgraduate Institute for Medicine and is supported by an educational grant from ViroPharma, Incorporated.

"Robert Michael Educational Institute LLC recognizes that continuing medical education plays a crucial role in the provision of quality health care and is dedicated to offering professionals meaningful opportunities for lifelong learning," says President and CEO, Robert M. Colleluori.

RMEI is a full-service medical education company dedicated to providing comprehensive medical education to healthcare providers. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For additional educational offerings, please visit http://www.RMEI.com.

Robert Michael Educational Institute LLC
http://www.RMEI.com

Article adapted by Medical News Today from original press release.
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Robert Michael Educational Institute LLC. "CMV Disease In Stem Cell Transplantation: Prevention And Drug Resistance." Medical News Today. MediLexicon, Intl., 15 Aug. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/118314.php>

APA
Robert Michael Educational Institute LLC. (2008, August 15). "CMV Disease In Stem Cell Transplantation: Prevention And Drug Resistance." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/118314.php.

Please note: If no author information is provided, the source is cited instead.


Infectious Diseases / Bacteria / Viruses

Most Popular Articles



Follow Our Infectious Diseases News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Infectious Diseases / Bacteria / Viruses Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »